comparemela.com

Latest Breaking News On - China sinovac life sciences co ltd - Page 3 : comparemela.com

Pharmaniaga to supply 12 mln Covid-19 vaccine doses to the govt

26 Jan 2021 / 20:17 H. Pix for illustration purposes. SHAH ALAM: Pharmaniaga Bhd (Pharmaniaga) will supply 12 million doses of CoronaVac Covid-19 vaccine to the Ministry of Health (MOH), following the signing of an agreement by both parties today. The agreement was signed by Minister of Health, Datuk Seri Dr Adham Baba on behalf of the MOH, and Pharmaniaga was represented by its group managing director, Datuk Zulkarnain Md Eusope. Zulkarnain said Pharmaniaga expects to receive the first supply of CoronaVac from China’s Sinovac Lifesciences Co Ltd (Sinovac) next month, and the vaccines will be available for the Malaysian by end of March or early April.

Health Ministry: Malaysia secures 18 4 million doses of Russian, Chinese Covid-19 vaccines | Malaysia

Tuesday, 26 Jan 2021 06:57 PM MYT BY JERRY CHOONG Pharmaniaga group managing director Datuk Zulkarnain Md Eusope and Health Minister Datuk Seri Dr Adham Baba pose after signing the agreement to supply Covid-19 vaccine January 26, 2021. Picture courtesy of Pharmaniaga Subscribe to our Telegram channel for the latest updates on news you need to know. KUALA LUMPUR, Jan 26 The Health Ministry has signed an agreement with local pharmaceutical companies Pharmaniaga Berhad and Duopharma (M) Sdn Bhd, who will jointly supply 18.4 million doses of Covid-19 vaccines from China and Russia for Malaysia. The agreement was signed earlier today by Health Minister Datuk Seri Dr Adham Baba, with Pharmaniaga represented by its group managing director Datuk Zulkarnain Md Eusope and Duopharma by its group managing director Leonard Ariff Abdul Shatar, respectively.

Pharmaniaga signs deal to supply 12 million doses of vaccine to MOH

CGS-CIMB upgrades Pharmaniaga to hold , raises target price to RM5 41

CGS-CIMB has upgraded Pharmaniaga Bhd to "hold" at RM5.27, with a higher target price (TP) of RM5.41 from RM4.15 previously, as the reseach house raised its earnings forecasts for the financial year ending Dec 31, 2021 (FY21) and FY22 to reflect Pharmaniaga's vaccine fill-and-finish venture contribution after sealing an agreement with China's Sinovac Life Sciences Co Ltd (Sinovac).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.